Global Sepsis Diagnostics Market Size, Share, Growth Analysis, By Technology(Blood Culture Technology and Immunoassays), By Application(Hospitals and Diagnostics Centres) - Industry Forecast 2024-2031

Global Sepsis Diagnostics Market size was valued at USD 0.67 billion in 2022 and is poised to grow from USD 0.74 billion in 2023 to USD 1.55 billion by 2031, growing at a CAGR of 9.8% during the forecast period (2024-2031).

The World Health Organization (WHO) reports that sepsis affects over 30 million people worldwide and results in 6 million deaths annually, with 3 million newborns and 1.2 million children affected. The high prevalence of sepsis is expected to increase the demand for diagnostic solutions, which will drive the growth of the sepsis diagnostic market. The current diagnostic tests for sepsis take up to 72 hours to provide final results, making the demand for rapid diagnostic tests high for early diagnosis. The market for sepsis diagnostic solutions is expected to grow rapidly in the coming years due to a number of factors.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Sepsis Diagnostics Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Sepsis Diagnostics Market Segmental Analysis

Worldwide Sepsis Market segments for diagnostics include type, application, and geography. The market can be divided into blood culture technology and immunoassays based on kind. The market is divided into diagnostic centers and hospitals based on application. The market is divided into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America based on geographic factors.

Drivers of the Global Sepsis Diagnostics Market

A major global health problem is the rising incidence of hospital-acquired infections (HAIs), also known as nosocomial infections. Pneumonia, sepsis, and urinary tract infections are some of the most common HAIs. Patients who are immunocompromised, old, or suffering from chronic conditions are among the susceptible patient populations where these infections can have very serious implications. With an annual increase of 8.7%, there is a concerning trend in the United States about the increased frequency of sepsis among hospitalized patients. As to the Centers for Disease Control and Prevention (CDC) data from 2018, the number of hospitalized patients in the United States who experience sepsis annually is anticipated to be over 1,000,000.

Restraints in the Global Sepsis Diagnostics Market

The high cost of developing and introducing into the market cutting-edge diagnostic solutions is one of the main obstacles to the global sepsis diagnostic industry. Furthermore, the general public's ignorance of sepsis and its symptoms may be impeding the market's expansion. Additionally, the availability of sepsis diagnostic technologies may be restricted in poorer nations due to a lack of healthcare infrastructure, which could impede market expansion. The strict regulatory structure that controls diagnostic solution approval might also provide difficulties for market-based producers.

Market Trends of the Global Sepsis Diagnostics Market

An important development in the global market for sepsis diagnostics is the growing use of point-of-care (POC) testing. POC tests are intended to diagnose sepsis quickly and precisely, which can greatly enhance patient outcomes. POC tests are perfect for use in emergency rooms, ambulances, and critical care units since they are portable, simple to use, and can be carried out outside of the conventional laboratory setting. Over the course of the projection period, there will likely be a rise in demand for POC testing due to the growing acceptance of digital health technologies and the necessity for quick diagnosis.